The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367 Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Mikolasevic, 2018, Nonalcoholic fatty liver disease and liver transplantation - where do we stand?, World J Gastroenterol, 24, 1491, 10.3748/wjg.v24.i14.1491 Riazi, 2019, Dietary patterns and components in nonalcoholic fatty liver disease (NAFLD): what key messages can health care providers offer?, Nutrients, 11, 10.3390/nu11122878 Boursier, 2020, Case-finding strategies in non-alcoholic fatty liver disease, JHEP Rep, 3 Perumpail, 2017, Clinical epidemiology and disease burden of nonalcoholic fatty liver disease, World J Gastroenterol, 23, 8263, 10.3748/wjg.v23.i47.8263 Younossi, 2019, Non-alcoholic fatty liver disease - a global public health perspective, J Hepatol, 70, 531, 10.1016/j.jhep.2018.10.033 Le, 2021, 2019 Global NAFLD prevalence: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 10.1016/j.cgh.2021.12.002 Li, 2019, Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis, Lancet Gastroenterol Hepatol, 4, 389, 10.1016/S2468-1253(19)30039-1 Zhou, 2019, Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis, Hepatology, 70, 1119, 10.1002/hep.30702 Cholongitas, 2021, Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis, Ann Gastroenterol, 34, 404 Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372, n71, 10.1136/bmj.n71 Pastori, 2020, Prevalence and impact of nonalcoholic fatty liver disease in atrial fibrillation, Mayo Clin Proc, 95, 513, 10.1016/j.mayocp.2019.08.027 Kalinowski, 2016, Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries, Addiction, 111, 1293, 10.1111/add.13341 Munn, 2015, Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data, Int J Evid-Based Healthc, 13, 147, 10.1097/XEB.0000000000000054 Wells Melsen, 2014, The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses, Clin Microbiol Infect, 20, 123, 10.1111/1469-0691.12494 Hunter, 2014, In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias, J Clin Epidemiol, 67, 897, 10.1016/j.jclinepi.2014.03.003 Kaplan Petta, 2018, Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: genetic and metabolic risk factors in a general population, Liver Int, 38, 2060, 10.1111/liv.13743 Zhai, 2017, Blood lead level is associated with non-alcoholic fatty liver disease in the Yangtze River Delta region of China in the context of rapid urbanization, Environ Health, 16, 93, 10.1186/s12940-017-0304-7 Amirkalali, 2014, Prevalence of non-alcoholic fatty liver disease and its predictors in north of Iran, Iran J Public Health, 43, 1275 Shi, 2021, Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity, Scand J Gastroenterol, 56, 312, 10.1080/00365521.2021.1879244 Han, 2019, Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: a cross-sectional study, Medicine (Baltimore), 98 Lonardo, 2019, Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps, Hepatology, 70, 1457, 10.1002/hep.30626 2016, EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease, Diabetologia, 59, 1121, 10.1007/s00125-016-3902-y Fedchuk, 2014, Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease, Aliment Pharmacol Ther, 40, 1209, 10.1111/apt.12963 Starekova, 2020, Liver fat quantification: where do we stand?, Abdom Radiol (NY), 45, 3386, 10.1007/s00261-020-02783-1 Caussy, 2018, Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials, Hepatology, 68, 763, 10.1002/hep.29797 Lonardo, 2017, Nonalcoholic fatty liver disease: evolving paradigms, World J Gastroenterol, 23, 6571, 10.3748/wjg.v23.i36.6571 Kim, 2013, Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States, Hepatology, 57, 1357, 10.1002/hep.26156 Zhang, 2021, Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: results from NHANES 2017-2018, PLoS One, 16 Lazo, 2013, Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994, Am J Epidemiol, 178, 38, 10.1093/aje/kws448 Perez, 2011, Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population, Prev Med, 52, 174, 10.1016/j.ypmed.2010.11.021 Karnikowski, 2007, Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults, Sao Paulo Med J, 125, 333, 10.1590/S1516-31802007000600006 Gallardo-Rincón, 2021, Review: type 2 diabetes in Latin America and the Caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention, Prim Care Diabetes, 15, 352, 10.1016/j.pcd.2020.10.001 Onyekwere, 2011, Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community, Ann Hepatol, 10, 119, 10.1016/S1665-2681(19)31559-5 Almobarak, 2014, Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: what is the prevalence and risk factors?, Arab J Gastroenterol, 15, 12, 10.1016/j.ajg.2014.01.008 Kramvis, 2007, Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes, Hepatol Res, 37, S9, 10.1111/j.1872-034X.2007.00098.x Paruk, 2019, Non-alcoholic fatty liver disease in Africa: a hidden danger, Glob Health Epidemiol Genom, 4, e3, 10.1017/gheg.2019.2 Abd El-Wahab, 2020, Validation of a non-laboratory based screening tool for predicting non-alcoholic fatty liver disease in an Egyptian setting, Am J Med Sci, 360, 662, 10.1016/j.amjms.2020.06.020 Cole, 2008, Constructing inverse probability weights for marginal structural models, Am J Epidemiol, 168, 656, 10.1093/aje/kwn164 Hernaez, 2011, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis, Hepatology, 54, 1082, 10.1002/hep.24452 Kitae, 2019, The triglyceride and glucose index is a predictor of incident nonalcoholic fatty liver disease: a population-based cohort study, Can J Gastroenterol Hepatol, 2019, 10.1155/2019/5121574 Kim, 2014, Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects, Liver Int, 34, 604, 10.1111/liv.12454 Hamaguchi, 2005, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease, Ann Intern Med, 143, 722, 10.7326/0003-4819-143-10-200511150-00009 Chang, 2018, Bidirectional association between nonalcoholic fatty liver disease and gallstone disease: a cohort study, J Clin Med, 7, 21, 10.3390/jcm7110458 Okamoto, 2018, Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: a longitudinal cohort study, PLoS One, 13, 10.1371/journal.pone.0195147 Zelber-Sagi, 2014, Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease, Liver Int, 34, e128, 10.1111/liv.12318 Okamura, 2019, Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study, J Gastrointestin Liver Dis, 28, 73, 10.15403/jgld.2014.1121.281.alc Wang, 2017, Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: a 7-year prospective study, Liver Int, 37, 1202, 10.1111/liv.13363 Kim, 2020, Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults, Metabolism, 103, 10.1016/j.metabol.2019.154026 Kim, 2020, Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease, Sci Rep, 10 Zhao, 2012, Relationship between components of metabolic syndrome and incidence of non-alcoholic fatty liver disease, J Dalian Med Univ, 34, 586 Wong, 2015, Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy, J Hepatol, 62, 182, 10.1016/j.jhep.2014.08.041 Yoshioka, 2020, Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis, Sci Rep, 10, 481, 10.1038/s41598-019-57369-9 Wu, 2015, Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease, Medicine (Baltimore), 94, e842, 10.1097/MD.0000000000000842 Jang, 2019, Cardiovascular health metrics in the development and regression of nonalcoholic fatty liver disease: a cohort study, J Clin Med, 8, 06, 10.3390/jcm8050610 Wang, 2018, Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study, Lipids Health Dis, 17, 196, 10.1186/s12944-018-0848-8